Validation pour Ingenuity264

vers la météo de la validation par utilisateur

Ingenuity264

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 45 - PMID ?

In male mutant SP with a homozygous knockout of SP NODE , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 1

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 2

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 3

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 4

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 5

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 6

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 7

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 8

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                  +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 9

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 10

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 11

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                  +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 12

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                  +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 13

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                  +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 14

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 15

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 16

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 17

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 18

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 19

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 20

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 21

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 22

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 23

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 24

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 25

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 26

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 27

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 28

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 29

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 30

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 31

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 32

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 33

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 34

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 35

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 36

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 37

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 38

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 39

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 40

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 41

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 42

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 43

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 44

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 45

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 46

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 47

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 48

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 49

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 50

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 51

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 52

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 53

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 54

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 55

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 56

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 57

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 58

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 59

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 60

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 61

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 62

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 63

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 64

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 65

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 66

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 67

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 68

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 69

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 70

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 71

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 72

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 73

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 74

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 75

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 76

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 77

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 78

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 79

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 80

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 81

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 82

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 83

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 84

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 85

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 86

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 87

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 88

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 89

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 90

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 91

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 92

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 93

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 94

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 95

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 96

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 97

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 98

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 99

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 100

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 101

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 102

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 103

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 104

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 105

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 106

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 107

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 108

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 109

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 110

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 111

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 112

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 113

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 114

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 115

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 116

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 117

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 118

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 119

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 120

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 121

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 122

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 123

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 124

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 125

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 126

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 127

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                  +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 128

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                  +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 129

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 130

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                  +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 131

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 132

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 133

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 134

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 135

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 136

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 137

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 138

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 139

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 140

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 141

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 142

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 143

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 144

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 145

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 146

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 147

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 148

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 149

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 150

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 151

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 152

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 153

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 154

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 155

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 156

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 157

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 158

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 159

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 160

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 161

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 162

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 163

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 164

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 165

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 166

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 167

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 168

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 169

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 170

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 171

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 172

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 173

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 174

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 175

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 176

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 177

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 178

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 179

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 180

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 181

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 182

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 183

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 184

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 185

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 186

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 187

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 188

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 189

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 190

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 191

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 192

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 193

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 194

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 195

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 196

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 197

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 198

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 199

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 200

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 201

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 202

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 203

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 204

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 205

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 206

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 207

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 208

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 209

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 210

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 211

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 212

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 213

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 214

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 215

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 216

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 217

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 218

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 219

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 220

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 221

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 222

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 223

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 224

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 225

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 226

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 227

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 228

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 229

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 230

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 231

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 232

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 233

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 234

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 235

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 236

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 237

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 238

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 239

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 240

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 241

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 242

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 243

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 244

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 245

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 246

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 247

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 248

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 249

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 250

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 251

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 252

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 253

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 254

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 255

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 256

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 257

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 258

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 259

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 260

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 261

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 262

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 263

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 264

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 265

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 266

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 267

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 268

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 269

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 270

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 271

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 272

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 273

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +----------------COMP:N-N(of)----------------+                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 274

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 275

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 276

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 277

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 278

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 279

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         +---COMP:N-N(of)---+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 280

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                            |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 281

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 282

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 283

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 284

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 285

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |                  |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 286

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 287

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 288

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 289

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 290

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 291

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 292

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 293

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 294

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 295

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 296

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 297

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 298

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 299

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 300

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 301

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 302

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 303

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 304

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 305

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 306

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 307

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |               +--------------------------APPOS--------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 308

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 309

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 310

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 311

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |                  |                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 312

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          +----------------------------------APPOS----------------------------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 313

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                  +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 314

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 315

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 316

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 317

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                  +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 318

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                  +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 319

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 320

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 321

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 322

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 323

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 324

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 325

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 326

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 327

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 328

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 329

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 330

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 331

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 332

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 333

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 334

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 335

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 336

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 337

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 338

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 339

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 340

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 341

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 342

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 343

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 344

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 345

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 346

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 347

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 348

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 349

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 350

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 351

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 352

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 353

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 354

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 355

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 356

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 357

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 358

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 359

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 360

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 361

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 362

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 363

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 364

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 365

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 366

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 367

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 368

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  |                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 369

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 370

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 371

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 372

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |                  |                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 373

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 374

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 375

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 376

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 377

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 378

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 379

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 380

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 381

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 382

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 383

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 384

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 385

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 386

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 387

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 388

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 389

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 390

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 391

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 392

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 393

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 394

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 395

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 396

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 397

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 398

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 399

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 400

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 401

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                                               |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 402

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 403

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 404

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 405

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 406

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 407

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                                               +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   +------------COMP:N-N(of)------------+                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
COMP:N-N(of) (__SP__,__SP__)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 408

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 409

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                            +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                                            |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                            |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 410

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                                     |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+COMP:N-N(o+                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 411

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 412

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 413

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +MOD_ATT:N-AD+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 414

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +---MOD_ATT:N-ADJ--+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 415

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 416

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 417

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                  +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+                      
                   |                         |                  |                  +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                  |                  |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |                  |                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          +MOD_ATT+        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__NODE__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 418

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                                    |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 419

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 420

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 421

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |                                     +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |                                     |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+     +----------------OBJ:V-N---------------+                  |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+     |         +MOD_ATT:N+COMP:N-N(o+       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |     |         |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
OBJ:V-N (with,__NODE__)
MOD_ATT:N-ADJ (knockout,homozygous)
COMP:N-N(of) (knockout,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 422

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 423

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |       +----------------------------------------------------SUBJ:V-N----------------------------------------------------+                      
                   |                         |          |       |                                                     +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |       +-------APPOS------+                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |       |        +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |       |        |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
APPOS (__NODE__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 424

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |               +--------------------------APPOS--------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |               |                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (bezafibrate,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 425

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 426

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 427

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 428

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          +----------------------------------APPOS----------------------------------+                   |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
APPOS (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 429

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 430

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 431

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 432

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 433

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 434

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 435

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 436

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 437

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+-----------COMP:N-N(of)-----------+        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (percent,year)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 438

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 439

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 440

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 441

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                                           |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 442

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------------COMP:N-N(of)------------------+        |                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+          |        |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |          |        |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+          |        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,year)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 443

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 444

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 445

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 446

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                                    +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                                    |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                                    |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+------COMP:N-N(with)-----+          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
COMP:N-N(with) (__SP__,knockout)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 447

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 448

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)

Analyse 449

                   +-------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------+                      
                   |                         +-----------------------------------------------------------COMP:V-N(with)----------------------------------------------------------+                      
                   |                         |          +------------------------------------------------------COMP:V-N(of)------------------------------------------------------+                      
                   |                         |          |                          +-------------------------------------------SUBJ:V-N------------------------------------------+                      
                   |                         |          |                          |                                  +-------------COMP:N-N(of)-------------+                   |                      
      +-MOD_ATT:N-N+                         |          |                          |                                  +-COMP:N-N(of)-+                       |                   |                      
      |     +MOD_AT+               +MOD_ATT:N+          |                +MOD_ATT:N+--COMP:N-N(of)-+                  |        +MOD_A+              +MOD_ATT:+COMP:N-N(o+        +-OBJ:V-N+COMP:N-N+    
      |     |      |               |         |          |                |         |               |                  |        |     |              |        |          |        |        |        |    
 In male mutant __SP__ with a homozygous knockout of __SP__ __NODE__ , oral administration of bezafibrate ( with a dosage of 00.5 percent and a treatment period of 1 year ) increases weight of liver .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (knockout,homozygous)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,bezafibrate)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,year)
COMP:V-N(In) (increase,__SP__)
COMP:V-N(with) (increase,knockout)
COMP:V-N(of) (increase,__SP__)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,weight)
COMP:N-N(of) (weight,liver)